Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2009
07/21/2009US7565273 Determination of the age, identification and sealing of a product containing volatile components
07/21/2009US7565251 Systems and methods for evaluating the significance of differences in biological measurements
07/21/2009US7565249 Method for the determination of a light transport parameter in a biological matrix
07/21/2009US7565247 Method for acquisition, storage, and retrieval of cell screening data on a computer system
07/21/2009US7564558 Gas cell
07/21/2009US7563902 Chemiluminescent compounds and their use
07/21/2009US7563897 Chemosensor exhibits excimer fluorescence
07/21/2009US7563891 Long wavelength thiol-reactive fluorophores
07/21/2009US7563880 Compositions and methods for the therapy and diagnosis of breast cancer
07/21/2009US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases
07/21/2009US7563875 Useful in assays for detecting human exposure to BoNT/A and BoNT/B; continuous myeloma cell line; kits
07/21/2009US7563867 PRO4356 polypeptides
07/21/2009US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage
07/21/2009US7563819 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
07/21/2009US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis
07/21/2009US7563624 surface plasmon resonance; both the amount of a physiologically active substance immobilized on the substrate and the biological activity of the physiologically active substance immobilized on the substrate are measured on said same biosensor
07/21/2009US7563623 nonspecific adsorption is less likely; a large amount of protein can be immobilized by having a hydrogel (polysaccharide) bind to biosensor via a SAM (self-assembled monolayer) compound (aminoalkanethiol) having high water solubility and good performance in terms of supply; surface plasmon resonance
07/21/2009US7563622 immunoassay; interfering exogenous material is cannabis or cocaine; interfering suppressant is molybdenyl acid triphosphate MoO(H2PO4)3 or molybdenyl trimetaphosphate MoO(PO3)3 or oxo- mu -oxodi(dihydrogen phosphate)molybdenum Mo2O3(H2PO4)4
07/21/2009US7563621 Absorbing organic reagents into diagnostic test devices by formation of amine salt complexes
07/21/2009US7563620 Using scanning laser cytometry to identify and record aggregates in cell suspensions; DNA histogram analysis and tumor diagnosis
07/21/2009US7563614 Systems and methods for rapidly changing the solution environment around sensors
07/21/2009US7563593 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents
07/21/2009US7563592 Alizarin-based chromogenic substrates, their uses and composition containing same
07/21/2009US7563591 Method for assaying the activity of lysosomal enzymes
07/21/2009US7563590 Methods of quantifying methotrexate metabolites
07/21/2009US7563587 Method and kit for cell analyte assay
07/21/2009US7563586 Tetrodotoxin resistant membrane protein for use in pain management
07/21/2009US7563585 Drug screening for inhibitors of the IL-4 receptor-mediated signaling cascade involved in B-cell isotype switching to, and consequent production of, IgE; allergies, eczema, asthma
07/21/2009US7563584 Simultaneously detecting the activation state of a plurality of proteins in single cells using flow cytometry; screening for bioactive agents capable of coordinately modulating the activity of a plurality of proteins in single cells; cancer
07/21/2009US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells
07/21/2009US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin
07/21/2009US7563567 Use of ECIST microarrays in an integrated method for assessing DNA methylation, gene expression and histone acetylation
07/21/2009US7563566 Stabilization of H2O2 under alkaline conditions for use in luminescence, fluorescence and colorimetric assays for enhanced detection of peroxidase type assays
07/21/2009US7563530 Fuel amount control system for fuel cell
07/21/2009US7563450 UL16 binding protein 4
07/21/2009US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy
07/21/2009US7563350 Small volume in vitro analyte sensor
07/21/2009US7563232 Method and apparatus for penetrating tissue
07/21/2009US7562774 Kit holding adapter
07/21/2009US7562562 Method and device for detecting a material
07/21/2009CA2479749C Test system for evaluating the compatibility of biologically active substances with copolymers
07/21/2009CA2445402C Apparatus with voraxial separator and analyzer
07/21/2009CA2349684C Method and apparatus for measuring the load bearing capacity of a platform
07/21/2009CA2329144C New peptide fragments for protein purification
07/21/2009CA2325886C Electronic techniques for analyte detection
07/21/2009CA2288996C A method and a system for determination of somatic cells in milk
07/18/2009CA2650095A1 Analyte testing method and system
07/17/2009CA2650878A1 Diluent wells produced in card format for immunodiagnostic testing
07/17/2009CA2648625A1 System and method for measuring an analyte in a sample
07/16/2009WO2009089543A2 Fluorescence detection system
07/16/2009WO2009089521A2 Predictors for evaluating response to cancer therapy
07/16/2009WO2009089512A2 Immune system modeling devices and methods
07/16/2009WO2009089466A2 System, apparatus and method for material preparation and/or handling
07/16/2009WO2009089286A1 Determination of sflt-1:angiogenic factor complex
07/16/2009WO2009089271A1 Calibrator/control for simultaneous assay of proteins capable of complexing with one another
07/16/2009WO2009089262A1 Stabilization of solid support assay reagents
07/16/2009WO2009089254A1 Immunomagnetic capture and imaging of biological targets
07/16/2009WO2009089189A2 Cell culture array system for automated assays and methods of operation and manufacture thereof
07/16/2009WO2009089130A2 Apparatus and method for determining analyte content in a fluid
07/16/2009WO2009089066A2 Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
07/16/2009WO2009089028A2 Insulin pump with convenience features
07/16/2009WO2009088989A1 Process for the preparation of capecitabine
07/16/2009WO2009088983A2 Insulin pump with insulin therapy coaching
07/16/2009WO2009088931A1 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability
07/16/2009WO2009088892A1 Liver screening method
07/16/2009WO2009088891A1 Screening method for selected amino lipid-containing compositions
07/16/2009WO2009088876A2 Transgenic non-human animals expressing human blood clotting factors
07/16/2009WO2009088837A2 Methods and products to target, capture and characterize stem cells
07/16/2009WO2009088801A1 Bifunctional and trifunctional nitrone spin trapping compounds and uses thereof
07/16/2009WO2009088781A1 Methods and systems for in situ physicochemical property testing
07/16/2009WO2009088779A2 Sers-based, single step, real-time detection of protein kinase and/or phosphatase activity
07/16/2009WO2009088694A1 Methods for detection of cyclosporin a
07/16/2009WO2009088492A1 Optical separator and method for separating particles suspended in a fluid
07/16/2009WO2009088461A2 5-nitrovaniiilin as a calibrant for calibrating the drift time for an ion mobility spectrometer
07/16/2009WO2009088460A2 Methods of diagnosing latent and active malignancies
07/16/2009WO2009088297A2 Sensor and detection device for use of the sensor
07/16/2009WO2009088283A1 Method and apparatus for preparing cheese
07/16/2009WO2009088209A2 Method for selective labeling of protein produced by in vitro translation by using a marker from trna prepared by using in vitro transcription
07/16/2009WO2009088117A1 Tissue sample array apparatus
07/16/2009WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF
07/16/2009WO2009088082A1 Method for specifically detecting test substance using photocurrent, sensor unit used therefor, and measuring device
07/16/2009WO2009088054A1 Model animal having both pain in testis or testis-related discomfort actions and frequent urination
07/16/2009WO2009088022A1 Novel cancer marker, and diagnosis using the same
07/16/2009WO2009087978A1 Anti-cldn6 antibody
07/16/2009WO2009087967A1 Method for detecting a protein-protein interaction
07/16/2009WO2009087462A2 Ephrin type-a receptor 10 protein
07/16/2009WO2009087375A1 Apparatus and method for filtering biological material
07/16/2009WO2009087373A1 Surface functionalisation of plastic optical fibre
07/16/2009WO2009087263A1 Composition for improving liver metabolism and diagnostic method
07/16/2009WO2009087258A1 Portable device and method for determining the quality of a piece of meat
07/16/2009WO2009087247A1 Device and method for measuring the oxygen uptake rate of activated sludge for a determined concentration of a biodegradable organic substrate
07/16/2009WO2009087219A1 Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
07/16/2009WO2009087196A1 Method for measuring plk4 activity
07/16/2009WO2009087190A1 Means and methods for assessing the risk of patients presenting to emergency units based on gdf-15
07/16/2009WO2009087097A1 A fluorescent teo-hybrid (f2h) assay for direct visualization of protein interactions in living
07/16/2009WO2009087093A1 Method for determining the type of allergy
07/16/2009WO2009086907A1 Tape cassette for a medical handheld device and blood sugar measuring system
07/16/2009WO2009086802A1 Method and device for metering the supply of a urea solution
07/16/2009WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females)
07/16/2009WO2009070742A3 Methods and compositions for signal enhancement using multivalent interactions